{"id":562993,"title":"Notice: Tablet Scoring of Subsequent-entry Pharmaceutical Products - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T10:55:56.301000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-tablet-scoring-subsequent-entry-pharmaceutical-products.html","snippet":"Notice: Tablet Scoring of Subsequent-entry Pharmaceutical Products March 28, 2017 Our file number: 17-103376-453 Pursuant to Part C, Division 8 of the Food and Drug Regulations (FDR) and of Division 1 of the FDR, this Notice is to inform sponsors of Health Canada's position with…","rawSnapshotUrl":"/api/snapshots/raw/562993","browseUrl":"https://replay.healtharchive.ca/job-6/20260216105556/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-tablet-scoring-subsequent-entry-pharmaceutical-products.html#ha_snapshot=562993","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}